SAN DIEGO--(BUSINESS WIRE)--Jan. 27, 2009--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has appointed
Prashant Mehta, Ph.D. to the newly created Director of Business
Development position. Dr. Mehta has extensive biotechnology and
financial industry experience, and since 2006 has been Managing Director
of Gemini Strategies LLC, a manager of small-cap institutional funds
with investments in the life science and medical device industry.
"I am very excited to join the Aethlon team and look forward to
developing and delivering strategic initiatives that unwrap the immense
potential of the Hemopurifier(R) to benefit patients and our investors,"
stated Dr. Mehta.
Dr. Mehta was previously an investment banker at Granite Financial
Group, Inc., and a Principal at TSG Partners, where he developed
corporate strategies for life science, diagnostic, biotechnology and
medical device companies. Dr. Mehta has also served as Director of
Business Development and Research at Imgenex Corp., was a member of the
Bioinformatics Project Management group at Diversa Corp., and a
Scientist at Nanogen, Inc. and the Department of Neuropharmacology at
The Scripps Institute. Dr. Mehta completed his Postdoctoral Fellowship
at Duke University focusing on molecular biology of DNA replication.
"Prashant's unique spectrum of expertise allows him to confidently
navigate the science, business, and financial industry," stated Jim
Joyce, Chairman and CEO of Aethlon Medical. "His presence will further
increase the opportunities we have to leverage our Hemopurifier(R)
platform technology to establish business relationships in the United
States and abroad," concluded Joyce.
Dr. Mehta holds numerous degrees including a Ph.D. in Biochemistry from
the Indian Institute of Science in Bangalore, India; an M.Sc. in
Microbiology from M.S. University of Baroda in Baroda, India; and a
B.Sc. in Microbiology from Bombay University in Bombay, India.
